Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Hyperphagia 1Hematologic Neoplasms 1

Interventions

Cytarabine 465Cyclophosphamide 459fludarabine phosphate 277Rituximab 249Methotrexate 245Etoposide 203fludarabine 200Filgrastim 199Peripheral Blood Stem Cell Transplantation 180Busulfan 169Vincristine 163Dexamethasone 153Daunorubicin 151Azacitidine 145Mycophenolic Acid 142Whole-Body Irradiation 133Tacrolimus 127Imatinib Mesylate 127Cyclosporine 123Granulocyte Colony-Stimulating Factor 118Radiotherapy 113Melphalan 110Idarubicin 103Doxorubicin 101Mitoxantrone 97Decitabine 97Antilymphocyte Serum 97Lenalidomide 96Mercaptopurine 93Prednisone 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Glucose × Other hematologic neoplasm × Clear all
NCT04425642 2021-06-24

Effects of Parenteral Nutrition in HSCT

St. Petersburg State Pavlov Medical University

Phase NA Completed
120 enrolled
Other hematologic neoplasm

Hyperphagia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡